Major coronary artery bypass graft (CABG)–related bleeding (86%)
Digoxin: Because of inhibition of the P-gp transporter, digoxin concentrations may be elevated, increasing the risk of toxicity.
Monitor digoxin concentrations with initiation of, or any change in,<unk>  therapy
Monitor digoxin concentrations with initiation of, or any change in,<unk>  therapy
Cardiovascular
Ventricular pause (6%)
Atrial fibrillation
Hypertension (4%)
Chest pain
Hypotension(3%)
CNS
Headache (7%)
Dizziness (5%)
Fatigue (3%)
Syncope/pre-syncope/loss of consciousness (2%)
GI
Diarrhea, nausea (4%).
Hematologic
Non–CABG-related bleeding (9%)
Pulmonary
Dyspnea (14%)
Cough (5%)
Ventricular pause (6%)
Atrial fibrillation
Hypertension (4%)
Chest pain
Hypotension(3%)
Headache (7%)
Dizziness (5%)
Fatigue (3%)
Syncope/pre-syncope/loss of consciousness (2%)
Diarrhea, nausea (4%).
Non–CABG-related bleeding (9%)
Dyspnea (14%)
Cough (5%)
Ticagrelor
Clopidogrel
Ticlopidine
Rivaroxaban
Eptifibatide
Apixaban
Prasugrel
Warfarin